Central motor conduction time may predict response to fampridine in patients with multiple sclerosis

por Zeller, D, Reiners, K, Bräuninger, S, Buttmann, M
Publicado 2014

SUMOylation of the transcription factor NFATc1 leads to its subnuclear relocalization and IL2 repression by HDAC

por Nayak, A, Glöckner-Pagel, J, Vaeth, M, Buttmann, M, Bopp, T, Schmitt, E, Serfling, E, Berberich-Siebelt, F
Publicado 2009

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis

por Hahn, S., Trendelenburg, G., Scharf, M., Denno, Y., Brakopp, S., Teegen, B., Probst, C., Wandinger, K. P., Buttmann, M., Haarmann, A., Szabados, F., vom Dahl, M., Kümpfel, T., Eichhorn, P., Gold, H., Paul, F., Jarius, S., Melzer, N., Stöcker, W., Komorowski, L.
Publicado 2017

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS

por Schrewe, L., Lill, C. M., Liu, T., Salmen, A., Gerdes, L. A., Guillot-Noel, L., Akkad, D. A., Blaschke, P., Graetz, C., Hoffjan, S., Kroner, A., Demir, S., Böhme, A., Rieckmann, P., ElAli, A., Hagemann, N., Hermann, D. M., Cournu-Rebeix, I., Zipp, F., Kümpfel, T., Buttmann, M., Zettl, U. K., Fontaine, B., Bertram, L., Gold, R., Chan, A.
Publicado 2015